Year-end Sale % OFF 
Abstract
A number of recent reports suggest that vasopressin may improve organ perfusion and contribute usefully to the cardiovascular management of septic shock. The rationale for the use of vasopressin is its relative deficiency of plasma levels and hypersensitivity to its vasopressor effects during septic shock. Although it is being used more frequently, there are no randomized clinical trials comparing vasopressin as a first-line vasopressor. Key words: septic shock ; vasopressin; vasoconstrictor agents
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Anesthesiology and Resuscitation
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
